Lobbying disclosures · Lobbying report
GILD: third_quarter 2026 lobbying report
Issues related to regulation of prescription drugs and biologics
Follow GILD- Became public
- Oct 18, 2026, 4:58 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 11, 2026, 6:37 AM EST
Why this is connected
Exact legal-name match: GILEAD SCIENCES, INC. (https://www.sec.gov/Archives/edgar/data/882095/).
Reported lobbying amounts
Income: $75,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/87c1e508-d715-4f2b-8319-89289ac73b13/","filing_uuid":"87c1e508-d715-4f2b-8319-89289ac73b13","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/87c1e508-d715-4f2b-8319-89289ac73b13/print/","filing_document_content_type":"text/html","income":"75000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Jeffrey J. Kimbell","dt_posted":"2026-10-18T16:58:00-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"401 9th Street NW","registrant_address_2":"Suite 920","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":46038,"url":"https://lda.gov/api/v1/registrants/46038/","house_registrant_id":34381,"name":"JEFFREY J. KIMBELL & ASSOCIATES, INC.","description":"Consulting Firm","address_1":"401 9th Street NW","address_2":"Suite 920","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JEFFREY KIMBELL","contact_telephone":"+1 202-735-2590","dt_updated":"2026-10-19T16:46:08.608430-04:00"},"client":{"id":153973,"url":"https://lda.gov/api/v1/clients/153973/","client_id":1003934,"name":"GILEAD SCIENCES, INC.","general_description":"Pharmaceutical manufacturing.","client_government_entity":false,"client_self_select":null,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-10-17"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to regulation of prescription drugs and biologics","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42442,"prefix":"mr","prefix_display":"MR.","first_name":"JEFFREY","nickname":null,"middle_name":"J","last_name":"KIMBELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":60159,"prefix":null,"prefix_display":null,"first_name":"KEITH","nickname":null,"middle_name":null,"last_name":"STUDDARD","suffix":null,"suffix_display":null},"covered_position":"Legislative Director, Rep. Marsha Blackburn","new":false},{"lobbyist":{"id":67296,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"R","last_name":"RAY","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant, Rep. Mike Kelly","new":false},{"lobbyist":{"id":139878,"prefix":"mr","prefix_display":"MR.","first_name":"KENNETH","nickname":null,"middle_name":"LEE","last_name":"HODGE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68519,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"RUDLOFF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":53650,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"HERZOG","suffix":null,"suffix_display":null},"covered_position":"Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President","new":false},{"lobbyist":{"id":149308,"prefix":null,"prefix_display":null,"first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"KEMPER","suffix":null,"suffix_display":null},"covered_position":"Counsel, Sen. John Cornyn; Deputy Assistant Secretary for Legislation, U.S. Department of Health and Human Services; Counselor to the Secretary, U.S. Department of Health and Human Services","new":false},{"lobbyist":{"id":150293,"prefix":null,"prefix_display":null,"first_name":"BRETT","nickname":null,"middle_name":null,"last_name":"MEEKS","suffix":null,"suffix_display":null},"covered_position":"Deputy Health Policy Director, Senate Committee on Health, Education, Labor and Pensions; Deputy Press Secretary, Office of Senator Lamar Alexander","new":false},{"lobbyist":{"id":153987,"prefix":null,"prefix_display":null,"first_name":"KRISTIN","nickname":null,"middle_name":null,"last_name":"FRITSCH","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant, Office of Congresswoman Cathy McMorris Rodgers; Senior Legislative Assistant, Office of Congresswoman Cathy McMorris Rodgers; Professional Staff Member House Committee on Energy and Commerce","new":false},{"lobbyist":{"id":155140,"prefix":null,"prefix_display":null,"first_name":"MARK","nickname":null,"middle_name":null,"last_name":"PEREZ","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":true},{"lobbyist":{"id":155141,"prefix":null,"prefix_display":null,"first_name":"COOPER","nickname":null,"middle_name":null,"last_name":"CHAMBLEE","suffix":null,"suffix_display":null},"covered_position":"Intern, Sen. Tim Scott","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in GILD
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jun 19, 2026$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
$1K–$15K · Traded May 6, 2026 · disclosed Jun 19, 2026
- Jun 19, 2026$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
$1K–$15K · Traded May 6, 2026 · disclosed Jun 19, 2026 · Dependent
- Feb 26, 2026$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded Jan 27, 2026 · disclosed Feb 26, 2026 · Joint
- Oct 10, 2025$1K–$15K
Rep. Val T. Hoyle (D-OR-4)
$1K–$15K · Traded Sep 23, 2025 · disclosed Oct 10, 2025 · Spouse
- Sep 12, 2025$1K–$15K
Rep. Val T. Hoyle (D-OR-4)
$1K–$15K · Traded Oct 29, 2024 · disclosed Sep 12, 2025 · Spouse · filed 318 days later
- Jun 22, 2025$15K–$50K
Rep. Jefferson Shreve (R-IN-6)
$15K–$50K · Traded May 12, 2025 · disclosed Jun 22, 2025
- Jun 18, 2025$1K–$15K
Rep. Marjorie Taylor Greene (R-GA-14)
$1K–$15K · Traded Jun 6, 2025 · disclosed Jun 18, 2025
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.